Provided by Tiger Trade Technology Pte. Ltd.

Prestige

52.56
-0.2700-0.51%
Post-market: 52.560.00000.00%19:30 EDT
Volume:449.10K
Turnover:23.58M
Market Cap:2.49B
PE:14.70
High:53.83
Open:53.45
Low:51.86
Close:52.83
52wk High:71.07
52wk Low:42.62
Shares:47.32M
Float Shares:46.69M
Volume Ratio:1.06
T/O Rate:0.96%
Dividend:- -
Dividend Rate:- -
EPS(TTM):3.58
EPS(LYR):3.91
ROE:9.12%
ROA:4.58%
PB:1.30
PE(LYR):13.44

Loading ...

L’Oréal Downgraded to Sell on Signs of Softening Luxury Beauty Demand and Competitive Pressure in Prestige Segment

TIPRANKS
·
Apr 14

Jefferies Sticks to Their Buy Rating for Prestige Estates Projects Limited (PRESTIGE)

TIPRANKS
·
Apr 12

Prestige Estates Buys 50% Stake in Aaramnagar Realty to Drive Versova Project

TIPRANKS
·
Apr 10

Prestige Group Enters ₹9,000-Crore Premium Housing Project in Versova, Mumbai

TIPRANKS
·
Apr 10

Buy Rating on Amylyx: De-Risked Avexitide Phase III Study and Significant PBH Market Opportunity Support 2027 Launch Potential

TIPRANKS
·
Apr 08

Prestige Estates Posts Record FY26 Pre-Sales Above ₹30,000 Crore

TIPRANKS
·
Apr 08

Why Prestige Consumer Healthcare (PBH) Is Down 5.8% After Heightened Regulatory Scrutiny On Its OTC Portfolio

Simply Wall St.
·
Apr 07

Prestige Consumer Healthcare Up Nearly 5%, on Pace for Largest Percent Increase Since May 2025 -- Data Talk

Dow Jones
·
Apr 06

Prestige Estates Unveils ₹9,500-Crore Mega Township in Hyderabad

TIPRANKS
·
Apr 03

MBX Biosciences Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
Apr 03

Arihant Foundations, Prestige Estates JV Acquires Land in Chennai, India

MT Newswires Live
·
Mar 27

Prestige, Arihant Seal Major Padi Land Deal to Build ₹5,000-Crore Chennai Housing Project

TIPRANKS
·
Mar 26

Prestige Biopharma Announces Positive Topline Results from Comparative SAMSON-II Study for HD204, a Potential Biosimilar to Avastin (bevacizumab)

prnewswire
·
Mar 24

Prestige Consumer Healthcare: Accretive Breathe Right Acquisition Reinforces Buy Rating and $86 Target

TIPRANKS
·
Mar 23

Prestige Consumer Healthcare’s Breathe Right Acquisition: Strategic Expansion at an Attractive Valuation Supports Buy Rating

TIPRANKS
·
Mar 23

ATB Cormark Capital Markets Sticks to Its Buy Rating for Premium Brands (PBH)

TIPRANKS
·
Mar 23

Canaccord Genuity Keeps Their Buy Rating on Premium Brands (PBH)

TIPRANKS
·
Mar 22

Premium Brands (PBH) Receives a Hold from National Bank

TIPRANKS
·
Mar 22

Raymond James Sticks to Their Buy Rating for Premium Brands (PBH)

TIPRANKS
·
Mar 21

CIBC Sticks to Its Buy Rating for Premium Brands (PBH)

TIPRANKS
·
Mar 21